Literature DB >> 17874684

Renal cortical deterioration in children with spinal dysraphism: analysis of risk factors.

Sean M DeLair1, Jonathan Eandi, Marina J White, Thuan Nguyen, Anthony R Stone, Eric A Kurzrock.   

Abstract

BACKGROUND/
OBJECTIVE: Because hydronephrosis and reflux are reversible, we believe cortical loss represents true renal deterioration in children with spinal dysraphism. Our goal was to better define risk factors for cortical loss.
METHODS: After institutional review board approval, we reviewed the medical records of 272 children with spinal dysraphism. The following factors were evaluated: age, sex, renal and bladder imaging, urodynamic parameters, medications, catheterization program, continence, infections, and surgical history. Renal cortical loss was defined by scarring or a differential function greater than 15% using a nuclear scan. Univariate and multivariate logistic regression models were fitted to test the associations of specific variables with cortical loss.
RESULTS: Renal cortical loss was found in 41% of children with high-grade reflux vs. 2% of children without reflux. Univariate analysis showed only high-grade reflux and female sex to be independent risk factors. Controlling for age and sex, reflux and initiation of catheterization after 1 year of age are significant risk factors. High bladder pressure and hydronephrosis in the absence of reflux were not associated with cortical loss. Multivariate analysis showed that girls with reflux have a 55-fold increased risk of cortical loss.
CONCLUSION: By limiting the definition of renal deterioration to cortical loss, we identified relevant risk factors: reflux, female sex, and delayed initiation of clean intermittent catheterization. We have also discounted other suspected risk factors: hydronephrosis and elevated bladder pressure. Rather than continuing our focus on hydronephrosis and urodynamics, we believe more research and management debate should be afforded to females with reflux.

Entities:  

Mesh:

Year:  2007        PMID: 17874684      PMCID: PMC2031976          DOI: 10.1080/10790268.2007.11753966

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  22 in total

1.  Renal deterioration in myelodysplastic children: urodynamic evaluation and clinical correlates.

Authors:  E A Kurzrock; S Polse
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

2.  The prophylactic use of clean intermittent catheterization in the treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction.

Authors:  E Geraniotis; S A Koff; B Enrile
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

3.  Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment.

Authors:  H Y Wu; L S Baskin; B A Kogan
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

4.  The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy.

Authors:  R A Edelstein; S B Bauer; M D Kelly; M M Darbey; C A Peters; A Atala; J Mandell; A H Colodny; A B Retik
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

5.  Determinants of hydronephrosis and renal injury in patients with myelomeningocele.

Authors:  G A McLorie; R Perez-Marero; A Csima; B M Churchill
Journal:  J Urol       Date:  1988-11       Impact factor: 7.450

6.  Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring.

Authors:  H D Flood; M L Ritchey; D A Bloom; C Huang; E J McGuire
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

7.  An alternative approach to myelodysplasia management: aggressive observation and prompt intervention.

Authors:  J M Teichman; H C Scherz; K D Kim; D H Cho; M G Packer; G W Kaplan
Journal:  J Urol       Date:  1994-08       Impact factor: 7.450

8.  Relevance of detrusor hyperreflexia, vesical compliance and urethral pressure to the occurrence of vesicoureteral reflux in myelodysplastic patients.

Authors:  S Kobayashi; Y Shinno; H Kakizaki; K Matsumura; T Koyanagi
Journal:  J Urol       Date:  1992-02       Impact factor: 7.450

9.  The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.

Authors:  N G Kasabian; S B Bauer; F M Dyro; A H Colodny; J Mandell; A B Retik
Journal:  Am J Dis Child       Date:  1992-07

10.  An objective score to predict upper tract deterioration in myelodysplasia.

Authors:  N T Galloway; J A Mekras; M Helms; G D Webster
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

View more
  11 in total

Review 1.  Prevention of chronic kidney disease in spina bifida.

Authors:  Guido Filler; Mireille Gharib; Shelley Casier; Petra Lödige; Jochen H H Ehrich; Sumit Dave
Journal:  Int Urol Nephrol       Date:  2011-01-13       Impact factor: 2.370

Review 2.  Early Vs. Expectant Management of Spina Bifida Patients-Are We All Talking About a Risk Stratified Approach?

Authors:  Angelena B Edwards; Micah Jacobs
Journal:  Curr Urol Rep       Date:  2019-11-16       Impact factor: 3.092

Review 3.  Research Needs for Effective Transition in Lifelong Care of Congenital Genitourinary Conditions: A Workshop Sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases.

Authors:  Michael H Hsieh; Hadley M Wood; Brad E Dicianno; Nienke P Dosa; Veronica Gomez-Lobo; Tej K Mattoo; Rosalia Misseri; Jenna M Norton; Kathleen J Sawin; Peter Scal; James E Wright; Robert A Star; Tamara Bavendam
Journal:  Urology       Date:  2017-02-02       Impact factor: 2.649

4.  The predictive factors of hydronephrosis in patients with spina bifida: reports from China.

Authors:  Yan Ma; Bing Li; Longwang Wang; Xiaomin Han
Journal:  Int Urol Nephrol       Date:  2013-03-13       Impact factor: 2.370

5.  Pediatric enterocystoplasty: long-term complications and controversies.

Authors:  Eric A Kurzrock
Journal:  World J Urol       Date:  2008-10-10       Impact factor: 4.226

6.  Can We Further Improve the Quality of Nephro-Urological Care in Children with Myelomeningocele?

Authors:  Monika Miklaszewska; Przemysław Korohoda; Katarzyna Zachwieja; Michał Wolnicki; Małgorzata Mizerska-Wasiak; Dorota Drożdż; Jacek A Pietrzyk
Journal:  Int J Environ Res Public Health       Date:  2016-09-01       Impact factor: 3.390

7.  Renal Outcomes in Children with Operated Spina Bifida in Uganda.

Authors:  Helen J Sims-Williams; Hugh P Sims-Williams; Edith Mbabazi Kabachelor; Benjamin C Warf
Journal:  Int J Nephrol       Date:  2018-08-07

8.  Diagnostic Test Characteristics of Ultrasound Based Hydronephrosis in Identifying Low Kidney Function in Young Patients with Spina Bifida: A Retrospective Cohort Study.

Authors:  David I Chu; Lauren C Balmert; Liqi Chen; Cameron Arkin; Theresa Meyer; Ilina Rosoklija; Diana K Bowen; Kavita S Hodgkins; Robin M Bowman; Earl Y Cheng; Elizabeth B Yerkes; Tamara Isakova
Journal:  J Urol       Date:  2020-11-18       Impact factor: 7.450

Review 9.  The Management of the Pediatric Neurogenic Bladder.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-07-02

10.  Risk Factors Predicting Upper Urinary Tract Damage in Patients With Myelodysplasia: Data Analysis of 637 Cases From A Single Center.

Authors:  Han Deng; Zhaoxia Wang; Limin Liao; Juan Wu; Yue Wang
Journal:  Int Neurourol J       Date:  2021-05-14       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.